Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

ClinicalTrials.gov ID: NCT00811889

Public ClinicalTrials.gov record NCT00811889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week, Multi-center, Double-blind, Randomized, Placebo-controlled Phase IIb Trial to Determine the Effects of Bardoxolone Methyl (RTA 402) on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease With an eGFR of 20 - 45 mL/Min/1.73m2

Study identification

NCT ID
NCT00811889
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biogen
Industry
Enrollment
227 participants

Conditions and interventions

Interventions

  • Placebo Other
  • Bardoxolone Methyl (RTA 402) Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 29, 2009
Primary completion
May 30, 2010
Completion
Dec 30, 2010
Last update posted
May 28, 2025

2009 – 2010

United States locations

U.S. sites
42
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Montgomery Alabama 36106
Not listed Chula Vista California 91910
Not listed La Mesa California 91942
Not listed Mission Viejo California 92691
Not listed Orange California 92868
Not listed Riverside California 92505
Not listed San Dimas California 91773
Not listed Middlebury Connecticut 06762
Not listed Washington D.C. District of Columbia 20036
Not listed Brandon Florida 33511
Not listed Miami Florida 33173
Not listed Pembroke Pines Florida 33028
Not listed Port Charlotte Florida 33952
Not listed West Palm Beach Florida 33401
Not listed Marietta Georgia 30060
Not listed Chicago Illinois 60616
Not listed Peoria Illinois 61603
Not listed Baton Rouge Louisiana 70809
Not listed Portland Maine 04102
Not listed Baltimore Maryland 21237
Not listed Flint Michigan 48504
Not listed Brooklyn Center Minnesota 55430
Not listed Flushing New York 11355
Not listed Springfield Gardens New York 11413
Not listed Morehead City North Carolina 28557
Not listed Winston-Salem North Carolina 27103
Not listed Roseburg Oregon 97471
Not listed Allentown Pennsylvania 18103
Not listed Pittsburgh Pennsylvania 15224
Not listed Pittsburgh Pennsylvania 15240
Not listed Providence Rhode Island 02904
Not listed Nashville Tennessee 37205
Not listed Corpus Christi Texas 78404
Not listed Dallas Texas 75390
Not listed El Paso Texas 79935
Not listed Fort Worth Texas 76104
Not listed San Antonio Texas 78205
Not listed San Antonio Texas 78215
Not listed San Antonio Texas 78229
Not listed Salem Virginia 24153
Not listed Federal Way Washington 98003

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00811889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00811889 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →